Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-Patent Chemo-Regimens to Retain Dominance Despite New Launches

Albany, NY -- (ReleaseWire) -- 01/30/2015 -- GBI Research, a leading business intelligence provider, has released its latest research report: "Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches". The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, China, Australia and Japan. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Ovarian Cancer (OC).